Multicentre randomised phase II trial of gemcitabine+platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2
2014 · European Journal of Cancer · 141 citations
https://doi.org/10.1016/j.ejca.2014.10.009